当前位置:首页 - 行情中心 - 华东医药(000963) - 财务分析

华东医药

(000963)

  

流通市值:720.05亿  总市值:720.93亿
流通股本:17.52亿   总股本:17.54亿

华东医药(000963)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润9.14亿元,每股收益0.52元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益2456269.66万元,未分配利润1837155.06万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产3944715.97万元,负债1488446.31万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入10,735,787,899.8241,905,707,385.9131,477,654,750.520,965,065,605.67
营业总成本9,620,007,130.4337,493,020,210.8728,288,811,654.1318,876,799,219.53
营业利润1,132,257,266.344,324,737,325.93,215,352,175.022,081,114,934.02
利润总额1,104,950,943.824,301,513,879.473,133,883,552.062,048,552,611.28
净利润913,984,183.423,494,185,631.762,562,604,257.611,688,215,051.04
其他综合收益82,044,972.47-10,256,659.9917,675,896.3-6,285,502.28
综合收益总额996,029,155.893,483,928,971.772,580,280,153.911,681,929,548.76
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计22,407,223,702.9721,051,790,761.2921,253,464,648.1320,505,927,176.64
非流动资产合计17,039,935,979.3416,827,255,605.8616,241,789,077.4715,660,856,599
资产总计39,447,159,682.3137,879,046,367.1537,495,253,725.636,166,783,775.64
流动负债合计14,351,327,970.2413,794,235,373.0114,332,964,692.1413,292,911,227.47
非流动负债合计533,135,114.07521,056,082.02591,790,995.49592,601,715.86
负债合计14,884,463,084.3114,315,291,455.0314,924,755,687.6313,885,512,943.33
归属于母公司股东权益合计24,059,686,522.6223,060,051,397.3622,041,377,799.4221,760,294,487.74
股东权益合计24,562,696,59823,563,754,912.1222,570,498,037.9722,281,270,832.31
负债和股东权益合计39,447,159,682.3137,879,046,367.1537,495,253,725.636,166,783,775.64
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计10,114,621,423.5344,970,182,586.2633,916,294,589.9821,888,171,937.74
经营活动现金流出小计10,947,350,117.4141,221,253,703.9131,409,891,781.0719,612,915,456.3
经营活动产生的现金流量净额-832,728,693.883,748,928,882.352,506,402,808.912,275,256,481.44
投资活动现金流入小计53,101,907327,006,060.47312,710,390.47293,806,195.54
投资活动现金流出小计698,941,307.412,497,277,729.471,917,166,036.95963,310,268.91
投资活动产生的现金流量净额-645,839,400.41-2,170,271,669-1,604,455,646.48-669,504,073.37
筹资活动现金流入小计1,435,998,8485,250,514,515.63,886,821,367.52,843,628,553.96
筹资活动现金流出小计1,522,837,485.846,000,178,834.725,048,237,971.163,330,858,162.7
筹资活动产生的现金流量净额-86,838,637.84-749,664,319.12-1,161,416,603.66-487,229,608.74
汇率变动对现金及现金等价物的影响-3,115,685.5-47,001,718.4621,363,561.91-5,787,341.62
现金及现金等价物净增加额-1,568,522,417.63781,991,175.77-238,105,879.321,112,735,457.71
期末现金及现金等价物余额3,421,628,769.054,990,151,186.683,970,054,131.595,320,895,468.62
最新报告期:2025-05-13
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券宋硕,陈竹2.302.662.982025-05-13
广发证券李桠桐,罗佳荣2.312.733.032025-05-08
财通证券华挺,赵千,张文录2.302.592.952025-05-06
兴业证券孙媛媛,杨希成2.332.722.982025-04-29
西部证券李梦园2.312.622.942025-04-29
TOP↑